Morgens Waterfall Vintiadis & Co. Inc. Buys 1,100 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Morgens Waterfall Vintiadis & Co. Inc. increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,000 shares of the biotechnology company’s stock after acquiring an additional 1,100 shares during the period. Axon Enterprise makes up 4.5% of Morgens Waterfall Vintiadis & Co. Inc.’s investment portfolio, making the stock its 11th largest holding. Morgens Waterfall Vintiadis & Co. Inc.’s holdings in Axon Enterprise were worth $5,943,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth approximately $40,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise in the fourth quarter worth $45,000. Stonebridge Financial Group LLC purchased a new position in Axon Enterprise in the fourth quarter worth about $53,000. GPS Wealth Strategies Group LLC increased its position in shares of Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after purchasing an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth about $59,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 9,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the sale, the president now directly owns 308,714 shares of the company’s stock, valued at approximately $210,947,363.34. This represents a 2.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 19,964 shares of company stock valued at $12,189,275. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $724.77 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business has a fifty day moving average of $572.18 and a two-hundred day moving average of $588.52. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $732.17. The company has a market cap of $56.42 billion, a P/E ratio of 187.28, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company had revenue of $603.63 million during the quarter, compared to analysts’ expectations of $585.67 million. During the same period in the previous year, the company earned $1.15 EPS. The business’s quarterly revenue was up 31.3% compared to the same quarter last year. As a group, analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the topic of a number of research reports. Needham & Company LLC raised their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research report on Thursday, May 8th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Finally, JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $640.91.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.